A relatively small number of cell and gene therapies have become a clinical reality. But now the specialty pharmacy industry, and healthcare more generally, is bracing for a wave of cell and gene therapies that will force change and adaption. And, yes, the new therapies will be extremely costly.
Related Keywords
Evanston , Illinois , United States , Colin Russi , George Rafferty , Ramesh Srinivasan , Las Vegas , Stephen Kagan , Natalie Bedford , Pfizer , Mckesson , Amerisourcebergen , Global Medical Lead , Genetic Medicine , Early Pipeline , Rare Disease , Specialty Pharmacy Summit , Centerwell Specialty Pharmacy , Space Shuttle , International Space ,
comparemela.com © 2020. All Rights Reserved.